Table 3.
Effect of STOMP and Time on Analgesic Misuse Risk Perceptions.
| Factor (Reference) | β coefficient [95% CI], p-value |
|---|---|
| STOMP (Control) | 0.39 [−0.86, 1.64],.546 |
| Time (Baseline) | |
| Day 14 | −0.95 [−1.87, −0.03],.043 |
| Month 1 | −1.41 [−2.34, −0.48],.003 |
| Month 3 | −2.68 [−3.64, −1.73], < .001 |
| STOMP*Time (Control) | |
| Day 14 | 1.76 [0.53, 2.99],.005 |
| Month 1 | 1.07 [−0.17, 2.31],.092 |
| Month 3 | 2.13 [0.86, 3.40],.001 |
| Age | 0.11 [−0.10, 0.32],.314 |
| Female sex (Male) | 2.51 [1.41, 3.61], < .001 |
| Non-Hispanic White (Other race/ethnicity) | 0.83 [−0.42, 2.09],.192 |
| Baseline past year opioid use (None) | −1.24 [−2.67, 0.19],.090 |
| Baseline DSM-5 symptom score | −0.05 [−0.12, 0.02],.187 |
| Baseline ASSIST score | −0.22 [−0.36, −0.08],.002 |
Generalized estimating equation (GEE) repeated measures model statistics: Wald χ2 = 92.90 (obs. 1503, obs per group 437); p < .001; time centered at baseline. STOMP = Scenario-Tailored Opioid Messaging Program; CI = Confidence Interval; DSM = Diagnostic and Statistical Manual of Mental Disorders; ASSIST = Alcohol, Smoking and Substance Involvement Screening Test